CoChat

Sensitivity of VHL mutant kidney cancers to HIF2 inhibitors does not require an intact p53 pathway

Open access
Stransky, Laura A., Vigeant, Sean M., Huang, Bofu, West, Destiny, Denize, Thomas, Walton, Emily, Signoretti, Sabina, Kaelin, William G. · 2022 · Proceedings of the National Academy of Sciences
Cited by 35

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Significance: VHL tumor suppressor gene inactivation is a hallmark of clear cell renal cell carcinoma (ccRCC), the most common form of kidney cancer, and promotes tumor growth by stabilizing the hypoxia-inducible factor 2 (HIF2) transcription factor. HIF2 inhibitors appear to be helpful for some, but not all, ccRCC patients in clinical trials. Previous preclinical and clinical data suggested that only ccRCCs that can activate the p53 tumor suppressor in response to DNA damage would respond to HIF2 inhibitors. Here, we show that an intact p53 pathway is neither necessary nor sufficient for the sensitivity of ccRCCs to HIF2 inhibitors, suggesting that it would be premature to use p53 status to determine which ccRCC patients should be treated with a HIF2 inhibitor.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.2120403119

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 35

Metadata

Authors
Stransky, L. A., Vigeant, S. M., Huang, B., West, D., Denize, T., Walton, E., Signoretti, S., & Kaelin, W. G.
Venue
Proceedings of the National Academy of Sciences
Published
2022-03-31
Volume
119
Issue
14
Pages
e2120403119-e2120403119
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W4220876249
Cited by
35
References
19
FWCI
2.34
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sensitivity of VHL mutant kidney cancers to HIF2 inhibitors does not require an intact p53 pathway. https://app.cochat.ai/papers/10.1073/pnas.2120403119
The paper
Stransky, L. A., Vigeant, S. M., Huang, B., West, D., Denize, T., Walton, E., Signoretti, S., & Kaelin, W. G. (2022). Sensitivity of VHL mutant kidney cancers to HIF2 inhibitors does not require an intact p53 pathway. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2120403119

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.